Table of Contents
ISRN Vascular Medicine
Volume 2012, Article ID 769092, 10 pages
http://dx.doi.org/10.5402/2012/769092
Research Article

Adiponectin Fails in Improving Angiogenic Repair in Streptozocin-Treated or L e p r d b / d b Mice after Hind Limb Ischemia

1Center for Geriatric Medicine, Bezirksklinikum Regensburg, Universitätsstraße 84, 93053 Regensburg, Germany
2Department of Internal Medicine III, Heidelberg University, 69117 Heidelberg, Germany
3Translational & Experimental Medicine, Luxembourg Centre for Systems Biomedicine, Luxembourg
4Department of Medicine II, Saarland University, Medical Center, 66421 Homburg, Germany

Received 10 April 2012; Accepted 12 June 2012

Academic Editors: A. Habib, A. Paolicchi, and A. Shaish

Copyright © 2012 Kurt Belisle et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Grundy, H. B. Brewer Jr., J. I. Cleeman, S. C. Smith Jr., and C. Lenfant, “Definition of metabolic syndrome: report of the national heart, lung, and blood Institute/American heart Association conference on scientific issues related to definition,” Circulation, vol. 109, no. 3, pp. 433–438, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. B. Yilmaz, S. F. Biyikoglu, Y. Akin, U. Guray, H. L. Kisacik, and S. Korkmaz, “Obesity is associated with impaired coronary collateral vessel development,” International Journal of Obesity, vol. 27, no. 12, pp. 1541–1545, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Lind and H. Lithell, “Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia,” American Heart Journal, vol. 125, no. 5, pp. 1494–1497, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Yarom, H. Zirkin, G. Stammler, and A. G. Rose, “Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material,” Journal of Pathology, vol. 166, no. 3, pp. 265–270, 1992. View at Google Scholar · View at Scopus
  5. Y. Arita, S. Kihara, N. Ouchi et al., “Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity,” Biochemical and Biophysical Research Communications, vol. 257, no. 1, pp. 79–83, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Ouchi, S. Kihara, Y. Arita et al., “Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin,” Circulation, vol. 100, no. 25, pp. 2473–2476, 1999. View at Google Scholar · View at Scopus
  7. K. Hotta, T. Funahashi, Y. Arita et al., “Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 6, pp. 1595–1599, 2000. View at Google Scholar · View at Scopus
  8. M. Kumada, S. Kihara, S. Sumitsuji et al., “Association of hypoadiponectinemia with coronary artery disease in men,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 1, pp. 85–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Yamauchi, J. Kamon, Y. Minokoshi et al., “Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase,” Nature Medicine, vol. 8, no. 11, pp. 1288–1295, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Yamauchi, J. Kamon, H. Waki et al., “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity,” Nature Medicine, vol. 7, no. 8, pp. 941–946, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. D. E. Moller and J. P. Berger, “Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation,” International Journal of Obesity, vol. 27, supplement 3, pp. S17–S21, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Stefan and M. Stumvoll, “Adiponectin—its role in metabolism and beyond,” Hormone and Metabolic Research, vol. 34, no. 9, pp. 469–474, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Stumvoll and H. Häring, “The peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism,” Diabetes, vol. 51, no. 8, pp. 2341–2347, 2002. View at Google Scholar · View at Scopus
  14. Y. Okamoto, S. Kihara, N. Ouchi et al., “Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice,” Circulation, vol. 106, no. 22, pp. 2767–2770, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Arita, S. Kihara, N. Ouchi et al., “Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell,” Circulation, vol. 105, no. 24, pp. 2893–2898, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. L. F. Rodella, L. Vanella, S. J. Peterson et al., “Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes,” Drug Metabolism Letters, vol. 2, no. 4, pp. 290–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Ouchi, H. Kobayashi, S. Kihara et al., “Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells,” Journal of Biological Chemistry, vol. 279, no. 2, pp. 1304–1309, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Shibata, N. Ouchi, S. Kihara, K. Sato, T. Funahashi, and K. Walsh, “Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling,” Journal of Biological Chemistry, vol. 279, no. 27, pp. 28670–28674, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Kobayashi, N. Ouchi, S. Kihara et al., “Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin,” Circulation Research, vol. 94, no. 4, pp. 27–31, 2004. View at Google Scholar · View at Scopus
  20. R. Ouedraogo, X. Wu, S. Q. Xu et al., “Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway,” Diabetes, vol. 55, no. 6, pp. 1840–1846, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Liu, J. D. Thornton, M. V. Cohen, J. M. Downey, and S. W. Schaffer, “Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction,” Circulation, vol. 88, no. 3, pp. 1273–1278, 1993. View at Google Scholar · View at Scopus
  22. A. Bierhaus, K. M. Haslbeck, P. M. Humpert et al., “Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily,” Journal of Clinical Investigation, vol. 114, no. 12, pp. 1741–1751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. K. P. Hummel, M. M. Dickie, and D. L. Coleman, “Diabetes, a new mutation in the mouse,” Science, vol. 153, no. 3740, pp. 1127–1128, 1966. View at Google Scholar · View at Scopus
  24. N. Bahary, R. L. Leibel, L. Joseph, and J. M. Friedman, “Molecular mapping of the mouse db mutation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 21, pp. 8642–8646, 1990. View at Google Scholar · View at Scopus
  25. M. Barinaga, “Researchers nail down leptin receptor,” Science, vol. 271, no. 5251, p. 913, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Chen, O. Charlat, L. A. Tartaglia et al., “Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice,” Cell, vol. 84, no. 3, pp. 491–495, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Matsuda, I. Shimomura, M. Sata et al., “Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis,” Journal of Biological Chemistry, vol. 277, no. 40, pp. 37487–37491, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Fujio and K. Walsh, “Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner,” Journal of Biological Chemistry, vol. 274, no. 23, pp. 16349–16354, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Murohara, T. Asahara, M. Silver et al., “Nitric oxide synthase modulates angiogenesis in response to tissue ischemia,” Journal of Clinical Investigation, vol. 101, no. 11, pp. 2567–2578, 1998. View at Google Scholar · View at Scopus
  30. T. Couffinhal, M. Silver, L. P. Zheng, M. Kearney, B. Witzenbichler, and J. M. Isner, “Mouse model of angiogenesis,” American Journal of Pathology, vol. 152, no. 6, pp. 1667–1679, 1998. View at Google Scholar · View at Scopus
  31. D. Nagata, M. Mogi, and K. Walsh, “AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress,” Journal of Biological Chemistry, vol. 278, no. 33, pp. 31000–31006, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. M. P. Cohen, K. Sharma, Y. Jin et al., “Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy,” Journal of Clinical Investigation, vol. 95, no. 5, pp. 2338–2345, 1995. View at Google Scholar · View at Scopus
  33. A. A. Like, R. L. Lavine, P. L. Poffenbarger, and W. L. Chick, “Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria,” American Journal of Pathology, vol. 66, no. 2, pp. 193–224, 1972. View at Google Scholar · View at Scopus
  34. E. Adeghate, “Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review,” Molecular and Cellular Biochemistry, vol. 261, no. 1, pp. 187–191, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. D. G. Federman, D. M. Bravata, and R. S. Kirsner, “Peripheral arterial disease: a systemic disease extending beyond the affected extremity,” Geriatrics, vol. 59, no. 4, pp. 26–30, 2004. View at Google Scholar · View at Scopus
  36. A. Rivard, M. Silver, D. Chen et al., “Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF,” American Journal of Pathology, vol. 154, no. 2, pp. 355–363, 1999. View at Google Scholar · View at Scopus
  37. S. Schiekofer, G. Galasso, K. Sato, B. J. Kraus, and K. Walsh, “Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 8, pp. 1603–1609, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Formby and N. Miller, “Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 7, pp. 2438–2442, 1990. View at Google Scholar · View at Scopus
  39. Y. Fujishima, Y. Koide, T. Kaidoh, M. Nishimura, and T. O. Yoshida, “Restriction fragment length polymorphism analysis of major histocompatibility complex genes in the non-obese diabetic mouse strain and its non-diabetic sister strains,” Diabetologia, vol. 32, no. 2, pp. 118–125, 1989. View at Google Scholar · View at Scopus
  40. J. Frystyk, L. Tarnow, T. K. Hansen, H. H. Parving, and A. Flyvbjerg, “Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications,” Diabetologia, vol. 48, no. 9, pp. 1911–1918, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Hadjadj, R. Aubert, F. Fumeron et al., “Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects,” Diabetologia, vol. 48, no. 6, pp. 1088–1092, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Saraheimo, C. Forsblom, J. Fagerudd et al., “Serum adiponectin is increased in type 1 diabetic patients with nephropathy,” Diabetes Care, vol. 28, no. 6, pp. 1410–1414, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Hara, M. Horikoshi, H. Kitazato et al., “Absence of an association between the polymorphisms in the genes encoding adiponectin receptors and type 2 diabetes,” Diabetologia, vol. 48, no. 7, pp. 1307–1314, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Kadowaki and T. Yamauchi, “Adiponectin and adiponectin receptors,” Endocrine Reviews, vol. 26, no. 3, pp. 439–451, 2005. View at Publisher · View at Google Scholar · View at Scopus